UK Agency Recalls Flucloxacillin Due to Incorrect Leaflets
The UK's MHRA has initiated a Class 3 recall for certain batches of Flucloxacillin Capsules. This precautionary measure is due to packaging errors where the patient information leaflet for Amoxicillin was included instead of the correct one. The recall aims to prevent patients from receiving inaccurate medication information.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.